Received Jun 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | — | IM / LA |
ved Capvaxive vaccine. The following day (5/20/25) had fever, an elevated heart rate (increase from 83 to 88 bpm resting heart rate, and approx 24 hours after vaccination HR was as high as 118 while resting) and a very sore arm (pain 6/10). Patient overall didn't feel well. About a week after vaccination, developed a shingles rash in several areas, include L side of torso (2 spots, one mid side and one higher up) as well as some spots on the back of each arm just outside of the armpit area. This patient had chicken pox as a child and has not been vaccinated against shingles. Had one prior flare up of shingles in 2017 when undergoing a stressful life event. Nothing since until this episode. This is all self-report. Patient did not visit her physician. As of this report, shingles rash is resolving with only mild postherpetic neuralgia
none
hypertension, pre-diabetes
Tirzepatide; amlodipine, famotidine, fexofenadine, atorvastatin
none
HR monitored with Apple Watch